| Name: | Aprepitant Open-Ring Methyl Ester Impurity |
| Catalogue No. | VL1110016 |
| CAS No. | 219821-37-1 |
| Molecular Formula | C24H25F7N4O4 |
| Molecular Weight | 566.47 |
| Status | In-stock |
| IUPAC Name | Methyl 2-(2-((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl) morpholino)-1-iminoethyl)hydrazinecarboxylate |
| Description | Aprepitant Open-Ring Methyl Ester Impurity (CAS NO.-219821-37-1) IUPAC Name-Methyl 2-(2-((2R,3S)-2-((R)-1-(3,5-Bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl) morpholino)-1-iminoethyl)hydrazinecarboxylate. Aprepitant belongs to the neurokinin NK1 receptor antagonists class of agents. it is given in combination with other agents in order to prevent acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with highly emetogenic chemotherapy in adults. aprepitant (125mg da |
| References | Dando, Toni M., and Caroline M. Perry. “Aprepitant.” Drugs, vol. 64, no. 7, 2004, pp. 777–94, https://doi.org/10.2165/00003495-200464070-00013. Curran, Monique P., and Dean M. Robinson. “Aprepitant.” Drugs, vol. 69, no. 13, Sept. 2009, pp. 1853–78, https://doi.org/10.2165/11203680-000000000-00000. |
